Acceptability of a novel vaginal microbicide during a safety trial among low-risk women

Family Planning Perspectives

Volumn 32, Issue 4, 2000, Pages 184-188

  Bentley, M E ^a   Morrow, K M ^a   Fullem, A ^a   Chesney, M A ^a   Horton, S D ^a   Rosenberg, Z ^a   Mayer, K H ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; GEL; HIGH RISK POPULATION; HUMAN; INTERVIEW; PRURITUS; SEXUALITY; SEXUALLY TRANSMITTED DISEASE;

EID: 0345806528     PISSN: 00147354     EISSN: None     Source Type: Journal    
DOI: 10.2307/2648235     Document Type: Article

References (21)

1. Women and AIDS: Developing a New Health Strategy
2. Transforming AIDS prevention to meet women's needs: A focus on developing countries
3. Vaginal microbicides for preventing the sexual transmission of HIV
4. Female-controlled methods to prevent sexual transmission of HIV
5. Women's interest in vaginal microbicides
6. HIV prevention: The need for methods women can use
7. Challenges for the development of female controlled vaginal microbicides
8. Choosing Unsafe Sex: AIDS-Risk Denial Among Disadvantaged Women
9. Topical microbicides: Current status and research considerations for adolescent girls
10. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
11. Safety of nonoxynol-9 vaginal gel in Kenyan prostitutes
12. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases
13. The safety and tolerability of BufferGel, a novel vaginal microbicide studied in U.S. women
14. The safety and tolerability of BufferGel, a novel vaginal microbicide studied in U.S. women
15. Contraceptive acceptability research: Utility and limitations
16. Acceptability of spermicidal film and foaming tablets among women in three countries